Know Cancer

or
forgot password

Complementary and Alternative Medicine Usage Among Participants Enrolled in Phase I Oncology Clinical Trials


N/A
N/A
N/A
Open (Enrolling)
Both
Advanced Cancer

Thank you

Trial Information

Complementary and Alternative Medicine Usage Among Participants Enrolled in Phase I Oncology Clinical Trials


This survey study is intended to estimate the prevalence of use of CAM in patients who are
currently being treated in the Phase I Clinical Trials Program at UT MD Anderson Cancer
Center. The survey includes questions about socioeconomic characteristics (age, gender,
race, income, and education level), patients' diagnosis and patients' perceptions about
their prognosis, physicians' information and permission for patients' use of CAM, patients'
use of CAM (yes or no), decision-making (purpose of CAM use), resources and types of CAM.

Patients will be asked to drop the questionnaire into a box in a specified location after
completion of the questionnaire. Accrual is expected to be 50-100 patients per month. This
survey is expected to finish in 6 months.


Inclusion Criteria:



1) Patients with a clinical diagnosis of malignancy who are seen in the outpatient
oncology clinic.

Exclusion Criteria:

1) Presence of any clinically relevant condition that, in the opinion of the investigator/
coordinator, would interfere with completing the study including, but not limited to,
visual problems, cognitive impairment or acute mental illness.

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Prevalence of CAM use among patients enrolled in Phase I clinical trials (Questionnaire Response Rate)

Outcome Time Frame:

1 Year

Safety Issue:

No

Principal Investigator

Aung Naing, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

UT MD Anderson Cancer Center

Authority:

United States: Institutional Review Board

Study ID:

2009-0369

NCT ID:

NCT00949390

Start Date:

August 2009

Completion Date:

Related Keywords:

  • Advanced Cancer
  • Advanced Cancer
  • Advanced Malignancy
  • Complementary and Alternative Medicine
  • CAM
  • Investigational Cancer Therapeutics
  • Phase I Clinical Trials
  • Neoplasms

Name

Location
UT MD Anderson Cancer Center Houston, Texas  77030